Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Metabolomics. 2013 Mar 12;9(4):809–816. doi: 10.1007/s11306-013-0511-3

Table 1.

Experimental treatment groups

Group Cell culture medium
A (control) DMSO placebo
B CGX0290
C CGX0290 + palmitoleate
D CGX0290 + oleate

The four groups all received MDI differentiation compounds and the above treatments in the cell culture medium

MDI methylisobutylxanthine, dexamethasone, and insulin

SCD1 inhibitor CGX0290 in DMSO—10uM

Palmitoleate—0.05 mM

Oleate—0.05 mM